Swiss National Bank
JBIO

Swiss National Bank’s Jade Biosciences JBIO Stock Holding History

Swiss National Bank’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-606
Closed -$288K – 2545
2023
Q3 		$288K Buy
606
+143
+31% +$77.5K ﹤0.01% 2587
2023
Q2 		$278K Sell
463
-68
-13% -$43.5K ﹤0.01% 2594
2023
Q1 		$375K Sell
531
-60
-10% -$49.8K ﹤0.01% 2582
2022
Q4 		$607K Buy
+591
New +$429K ﹤0.01% 2530

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Swiss National Bank's JBIO Position: Q4 2023 in Review

Swiss National Bank sold out of Jade Biosciences (JBIO) in Q4 2023, closing a stake of 606 shares — an estimated $288K sold.

Swiss National Bank first reported a position in JBIO in Q4 2022 and held it in 4 quarters. The position peaked at $607K in Q4 2022. 64 funds tracked by Wall St. Rank hold JBIO as of Q4 2023.

  • Swiss National Bank reported no remaining Jade Biosciences position as of Q4 2023 after selling out during the quarter.
  • Swiss National Bank sold 606 Jade Biosciences shares in Q4 2023, an estimated $288K.
  • Swiss National Bank first reported a position in Jade Biosciences in Q4 2022 and held it in 4 quarters.
  • Swiss National Bank's Jade Biosciences position peaked at $607K in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Jade Biosciences as of Q4 2023.

Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.